(2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5R)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4,5-tris[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | 1980-14-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5R)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4,5-tris[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
• CAS: 1980-14-9；23846-82-4
• 化学式: C₄₂H₇₂O₃₆
• 分子量: 1153.0
• InChiKey: WWDPIUOBYLGGIJ-KIXFCQHQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -12.7
• 重原子数：
  78
• 可旋转键数：
  19
• 环数：
  7.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  585
• 氢给体数：
  23
• 氢受体数：
  36

文献信息

• Oligosaccharide compositions and methods of use thereof
  申请人：Kaleido Biosciences, Inc.

  公开号：US11169101B2

  公开（公告）日：2021-11-09

  Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of related diseases.

  本公开的各个方面涉及寡糖组合物及其制造方法。还提供了将寡糖组合物用作微生物组代谢疗法以降低氨水平和治疗相关疾病的方法。
• OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR REDUCING AMMONIA LEVELS
  申请人：Kaleido Biosciences, Inc.

  公开号：EP3841127A2

  公开（公告）日：2021-06-30
• OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF
  申请人：Kaleido Biosciences, Inc.

  公开号：EP3877424A2

  公开（公告）日：2021-09-15
• [EN] OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR REDUCING AMMONIA LEVELS<br/>[FR] COMPOSITIONS D'OLIGOSACCHARIDES ET LEURS PROCÉDÉS D'UTILISATION POUR REDUIRE LES NIVEAUX D'AMMONIAQUE
  申请人：KALEIDO BIOSCIENCES INC

  公开号：WO2020041531A2

  公开（公告）日：2020-02-27

  Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of hyperammonemia-related diseases (e.g., urea cycle disorders and hepatic encephalopathy).
• [EN] OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF<br/>[FR] COMPOSITIONS OLIGOSACCHARIDIQUES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：KALEIDO BIOSCIENCES INC

  公开号：WO2020227689A1

  公开（公告）日：2020-11-12

  Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing pathogen levels and/or abundance and for the treatment of related diseases.